Cause of death, by non-communicable diseases, ages 15-59, male in Least developed countries
Least developed countries: Cause of death, by non-communicable diseases, ages 15-59, male was 40.4% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 15-59, male in Least developed countries, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 15-59.
Analysis
Least developed countries recorded 40.4% for cause of death, by non-communicable diseases, ages 15-59, male in 2021.
The figure is down 7.4% on the previous year and up 3.2% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 15-59, male in Least developed countries peaked at 44.4% in 2019 and was at its lowest, 33.2%, in 2000.
That places Least developed countries 37th out of 47 groups with data for 2021, putting it in the bottom quarter.
Cause of death, by non-communicable diseases, ages 15-59, male in Least developed countries, year by year
| Year | % of total male deaths ages 15-59 | Change |
|---|---|---|
| 2000 | 33.2% | — |
| 2010 | 39.1% | +17.8% |
| 2015 | 42.0% | +7.3% |
| 2019 | 44.4% | +5.9% |
| 2020 | 43.6% | -1.8% |
| 2021 | 40.4% | -7.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 33.2% | 33.2% | 33.2% | 1 |
| 2010s | 41.8% | 39.1% | 44.4% | 3 |
| 2020s | 42.0% | 40.4% | 43.6% | 2 |
Countries ranked near Least developed countries
More health data for Least developed countries
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, annual growth rate 3.29 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.0255 units per person (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, annual growth rate 3.94 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.0286 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate 2.37 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.03 units per person (2025)
- Population ages 30-34, female, annual growth rate 3.32 % change on previous year (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 15-59, male in Least developed countries?
- Cause of death, by non-communicable diseases, ages 15-59, male in Least developed countries was 40.4% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 15-59, male recorded in Least developed countries?
- The highest recorded value was 44.4% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 15-59, male recorded in Least developed countries?
- The lowest recorded value was 33.2% in 2000.
- How does Least developed countries rank for cause of death, by non-communicable diseases, ages 15-59, male?
- Least developed countries ranks 37th out of 47 groups with data for 2021.
- Is cause of death, by non-communicable diseases, ages 15-59, male rising or falling in Least developed countries?
- Over the last ten years it is up 3.2%. The long-run trend across the full record is rising.
- Where does this Least developed countries data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.